AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Schold, SC Kuhn, JG Chang, SM Bosik, ME Robins, HI Mehta, MP Spence, AM Fulton, D Fink, KL Prados, MD
Citation: Sc. Schold et al., A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide:A North American brain tumor consortium study. (vol 2, pg 34, 2000), NEURO-ONCOL, 3(2), 2001, pp. 123-123

Authors: Muzi, M Freeman, SD Burrows, RC Wiseman, RW Link, JM Krohn, KA Graham, MM Spence, AM
Citation: M. Muzi et al., Kinetic characterization of hexokinase isoenzymes from glioma cells: Implications for FDG imaging of human brain tumors, NUCL MED BI, 28(2), 2001, pp. 107-116

Authors: Bethune, CR Geyer, RJ Spence, AM Ho, RJY
Citation: Cr. Bethune et al., Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats, CANCER RES, 61(9), 2001, pp. 3669-3674

Authors: Chang, SM Kuhn, JG Robins, HI Schold, SC Spence, AM Berger, MS Mehta, MP Pollack, IF Rankin, C Prados, MD
Citation: Sm. Chang et al., A phase II study of paclitaxel in patients with recurrent malignant gliomausing different doses depending upon the concomitant use of anticonvulsants - A North American Brain Tumor Consortium report, CANCER, 91(2), 2001, pp. 417-422

Authors: Schold, SC Kuhn, JG Chang, SM Bosik, ME Robins, HI Mehta, MP Spence, AM Fulton, D Fink, KL Prados, MD
Citation: Sc. Schold et al., A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide:A North American Brain Tumor Consortium study, NEURO-ONCOL, 2(1), 2000, pp. 34-39

Authors: Pilon, M Peng, XR Spence, AM Plasterk, RHA Dosch, HM
Citation: M. Pilon et al., The diabetes autoantigen ICA69 and its Caenorhabditis elegans homologue, ric-19, are conserved regulators of neuroendocrine secretion, MOL BIOL CE, 11(10), 2000, pp. 3277-3288

Authors: Lum, DH Kuwabara, PE Zarkower, D Spence, AM
Citation: Dh. Lum et al., Direct protein-protein interaction between the intracellular domain of TRA-2 and the transcription factor TRA-1A modulates feminizing activity in C. elegans, GENE DEV, 14(24), 2000, pp. 3153-3165

Authors: Mehra, A Gaudet, J Heck, L Kuwabara, PE Spence, AM
Citation: A. Mehra et al., Negative regulation of male development in Caenorhabditis elegans by a protein-protein interaction between TRA-2A and FEM-3, GENE DEV, 13(11), 1999, pp. 1453-1463

Authors: Chang, SM Kuhn, JG Robins, HI Schold, SC Spence, AM Berger, MS Mehta, MP Bozik, ME Pollack, I Schiff, D Gilbert, M Rankin, C Prados, MD
Citation: Sm. Chang et al., Phase II study of phenylacetate in patients with recurrent malignant glioma: A North American brain tumor consortium report, J CL ONCOL, 17(3), 1999, pp. 984-990

Authors: Chen, SH Zhou, SH Sarkar, M Spence, AM Schachter, H
Citation: Sh. Chen et al., Expression of three Caenorhabditis elegans N-acetylglucosaminyltransferaseI genes during development, J BIOL CHEM, 274(1), 1999, pp. 288-297

Authors: Eary, JF Mankoff, DA Spence, AM Berger, MS Olshen, A Link, JM O'Sullivan, F Krohn, KA
Citation: Jf. Eary et al., 2-[C-11]thymidine imaging of malignant brain tumors, CANCER RES, 59(3), 1999, pp. 615-621
Risultati: 1-11 |